Literature DB >> 11079142

Dendritic cell-based immunotherapy of cancer.

L Zitvogel1, E Angevin, T Tursz.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11079142     DOI： 10.1093/annonc/11.suppl_3.199

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Cell-based immunotherapy of prion diseases by adoptive transfer of antigen-loaded dendritic cells or antigen-primed CD(4+) T lymphocytes.

Authors:  Claude Carnaud; Véronique Bachy
Journal:  Prion       Date:  2010-04-04       Impact factor: 3.931

2.  Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination.

Authors:  Xinyuan Chen; Qiyan Zeng; Mei X Wu
Journal:  Clin Cancer Res       Date:  2012-03-05       Impact factor: 12.531

3.  Comparison of three culture media for the establishment of melanoma cell lines.

Authors:  M C Pandolfino; S Saïagh; A C Knol; B Dréno
Journal:  Cytotechnology       Date:  2010-08-21       Impact factor: 2.058

Review 4.  The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors.

Authors:  Peter E Fecci; Duane A Mitchell; Gary E Archer; Michael A Morse; H Kim Lyerly; Darell D Bigner; John H Sampson
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

5.  Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells.

Authors:  Loc T Nguyen; Suresh Radhakrishnan; Bogoljub Ciric; Koji Tamada; Tahiro Shin; Drew M Pardoll; Lieping Chen; Moses Rodriguez; Larry R Pease
Journal:  J Exp Med       Date:  2002-11-18       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.